SpaceOAR hydrogel complications in prostate cancer
- PMID: 37750832
- PMCID: PMC10646634
- DOI: 10.1259/bjr.20230717
SpaceOAR hydrogel complications in prostate cancer
Abstract
SpaceOAR hydrogel, a novel biodegradable spacer, is increasingly used in managing prostate cancer patients undergoing radiation therapy to minimize rectal radiation dose and associated complications. However, its use has raised new concerns regarding its potential complications and impact on subsequent imaging interpretation. This article provides a pictorial review of the imaging complications of using SpaceOAR hydrogel in prostate cancer patients. We present multiple examples demonstrating the types of complications that can occur, potential underlying mechanisms, and their impact on patient outcomes and imaging interpretation. This review aims to provide radiologists and oncologists with an updated understanding of these complications, guiding better patient management and interpretation of imaging studies.
Figures












References
-
- Uhl M, van Triest B, Eble MJ, Weber DC, Herfarth K, De Weese TL. Low Rectal toxicity after dose escalated IMRT treatment of prostate cancer using an Absorbable Hydrogel for increasing and maintaining space between the Rectum and prostate: results of a multi-institutional phase II trial. Radiother Oncol 2013; 106: 215–19. doi: 10.1016/j.radonc.2012.11.009 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical